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ABSTRACT
Modulation of the expression of hepatic and renal genes
encoding xenobiotic metabolizing enzymes by an aspalathin-
enriched green rooibos (Aspalathus linearis) extract (GRE) was
investigated in the liver and kidneys of F344 rats following
dietary exposure of 28 d, as well as selected xenobiotic me-
tabolizing genes in rat primary hepatocytes. In the liver, GRE
upregulated genes (p < 0.05) encoding aldehyde dehydrogen-
ase, glucose phosphate isomerase, and cytochrome P450
while 17β-hydroxysteroid dehydrogenase 2 (Hsd17β2) was
downregulated. In primary hepatocytes, GRE lacked any ef-
fect, while aspalathin downregulated Hsd17β2, mimicking
the effect of GRE in vivo, and upregulated catechol-O-methyl
transferase and marginally (p < 0.1) cytochrome P450 2e1. In
the kidneys, GRE upregulated (p < 0.05) genes encoding the
phase II xenobiotic metabolism enzymes, glutathione-S-trans-
ferase mµ and microsomal glutathione-S-transferase, while
downregulating genes encoding the ATP binding cassette
transporter, cytochrome P450, gamma glutamyltransferase
1, and N-acetyltransferase 1. Differential modulation of the
expression of xenobiotic metabolizing genes in vivo and in
vitro by GRE is dose-related, duration of exposure, the tissue
type, and interactions between specific polyphenol and/or
combinations thereof. Aspalathin is likely to be responsible
for the downregulation of estradiol and testosterone catabo-
lism by GRE in the liver. The differential gene expression by
GRE in the liver and kidneys could, depending on the duration
exposure and dose utilized, determine the safe use of such an
extract in humans for specific health and/or disease out-
comes.
Differential Modulation of Gene Expression Encoding Hepatic
and Renal Xenobiotic Metabolizing Enzymes by an Aspalathin-

































Xenobiotics, such as polyphenols, are foreign substances entering
the body and can either be beneficial or harmful, depending on
the dose and/or their metabolic fate. They may interact with the
cellular metabolic pathways and cellular constituents such as
membrane lipids, proteins, and DNA, often leading to the modu-
lation of normal cellular functions [1]. Most xenobiotics undergo6
metabolism that include phase I, phase II metabolizing enzymes
and phase III transporters, present in abundance either at the ba-
sal and/or at induced levels following exposure, and these interac-
tions may trigger cellular “stress” responses, leading to an in-
crease in gene expression, ultimately enhancing their elimination
[2,3]. Consequently, these homeostatic responses play a central
role in the protection of cells against “environmental” insults such
as those elicited by exposure to xenobiotics.Abrahams S et al. Differential Modulation of… Planta Med 2019; 85: 6–13
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Cyp2e1 cytochrome P450 2e1
Cyp4b1 cytochrome P450 4b1
Cyp19a1 cytochrome P450 19a1
GAE gallic acid equivalents
Ggt1 gamma glutamyltransferase 1
Gpi glucose phosphate isomerase
Gstm1 glutathione-S-transferase mµ
GRE green rooibos extract
Gst glutathione-S-transferase
HED human equivalent dose
Hk2 hexokinase 2
Hprt1 hypoxanthine guanine phosphoribosyl
transferase 1
Hsd17β2 17β-hydroxysteroid dehydrogenase 2
IC50 concentration inhibiting 50% of cell viability
IL-16 interleuken 16
Ldha lactate dehydrogenase A
LPS lipopolysaccharide




NF-κB nuclear factor kappa-light-chain-enhancer of
activated B cells
nrf2 nuclear factor erythroid 2-related factor 2
qRT‑PCR quantitative reverse transcription polymerase
chain reaction
Rpl13a ribosomal protein L13A
Rplp1 ribosomal protein large P1
Sult sulfotransferase
TNF-α tumor necrosis factor α
TP total polyphenols
WE Williamsʼ E medium
UDP Uridine 5′-diphosphate
Ugt UDP-glucuronyltransferase
▶ Fig. 1 Chemical structure of aspalathin, the major dihydrochal-






























l.The herbal tea, rooibos (Aspalathus linearis [Burm.f.] R.Dahl-
gren, Leguminosae), has become increasingly popular for its
unique flavor and health promoting properties [4]. For the pro-
duction of nutraceutical extracts, especially those with antidia-
betic properties, the “unfermented” product (green rooibos) is
preferred due to the high levels of the antioxidant and antidiabetic
[5] dihydrochalcone, aspalathin (▶ Fig. 1). At present, very little is
known about the effects of rooibos on xenobiotic metabolism, es-
pecially when utilizing polyphenol-enriched extracts and aspala-
thin, the major rooibos flavonoid. Studies indicated that rooibos
extracts exhibited drug interactions through the modulation ofAbrahams S et al. Differential Modulation of… Planta Med 2019; 85: 6–13cytochrome P450 (CYP) protein expression in the liver of rats [6].
An extract of unfermented rooibos enhances the activity of the
phase II drug metabolizing enzymes, glutathione-S-transferase
and UDP-glucuronosyltransferase in the liver of rats [7]. Dietary
exposure of rats to a fermented rooibos extract increased the ex-
pression of CYP3A4 in the gut accompanied by a significant de-
crease in the serum concentration of 4-hydroxymidazolam, a drug
known to be metabolized by the enzyme [8]. Rooibos flavonoids
were shown to modulate steroid hormone levels in vitro by inhib-
iting key enzymes in the adrenal steroidogenic pathway [9], while
rooibos extracts and aspalathin inhibit the activity of cytochrome
P450 enzymes involved in the metabolism of hypoglycemic and
hypolipidemic drugs [10]. These investigations emphasize the im-
portance to elucidate the potential beneficial and/or adverse ef-
fects of polyphenol-enriched extracts of rooibos when utilized as
nutraceutical supplements.
In the present study, the effect of an aspalathin-enriched GRE
on the expression of genes encoding xenobiotic metabolizing en-
zymes was investigated in rat liver and kidneys. The same extract
was utilized demonstrating antidiabetic properties [11] and the
modulation of the expression of antioxidant defense and oxidative
stress-related genes in the liver of rats [12]. Additional experi-
ments included the modulating role of GRE and aspalathin on
the expression of selected xenobiotic metabolizing enzymes in
primary rat hepatocytes.Results
Daily intake of feed supplemented with GRE had no significant ef-
fect on BW gain, clinical chemical parameters, and relative liver
and kidney weights of rats as reported previously [12]. Further-
more, feed intake was not significantly different between the
treated and control rats, averaging respectively 97.3 and 96.5 g/
kg BW. This feed intake equaled a daily TP intake of 76mg GAE/
kg BW, an aspalathin intake of 36mg/kg, and other major flavo-
noids, including the rooibos flavones and flavonols, of 14mg/kg
BW.
Of the 84 genes analyzed, only four genes were significantly
(p ≤ 0.05) affected in the liver by GRE (▶ Table 1). Three genes,
Ald1a1, Cyp19a1, and Gpi, were upregulated, whereas Hsd17β2
was downregulated. Downregulation of Hsd17β1 (− 1.81) was
not significant. Marginal changes included upregulation of non-
muscle cytoskeletal beta actin (Actb) and downregulation of
Smarcal1_predicted (matrix-associated, actin-dependent regulator
of chromatin, subfamily a like 1), Alox 15, and MPO. The major7
▶ Table 1 Differential gene expression profile of xenobiotic metabolizing enzymes in the liver and kidneys of rats following exposure to GRE for 28 d.
Gene Liver Gene Kidneys
Ald1a1 + 2.39 (0.05) Abcb1 − 1.85 (0.01)
Cyp19a1 + 1.98 (0.02) Cyp4b1 − 2.19 (0.05)
Gpi + 2.48 (0.007) Ggt1 − 1.69 (0.02)
Hsd17β2 − 2.42 (0.008) Gstm1 + 1.57 (0.05)
Alox15 − 1.23 (0.098) Mgst1 + 1.29 (0.01)
MPO − 1.82 (0.1) Nat1 − 1.22 (0.02)
Actb +1.22(0.085)
Smarcal1_predicted − 1.66(0.07)
The values indicate fold differences. Numbers in brackets signify p ≤ 0.05; – indicates genes downregulated; + indicates genes upregulated. 0.1 ≥ p > 0.05
indicated marginal differences
▶ Table 2 Concentration of GRE and aspalathin required to inhibit
50% ATP production and levels utilized for gene expression analyses









Aspalathin 1.91 (1.85–1.97)** 0.31mM
*Means (95% confidence intervals) of five replications of two indepen-
dent experiments. *IC50: inhibition of 50% of ATP production. #Values
represents the equivalent aspalathin concentration in GRE.
▶ Table 3 Gene expression induction/inhibition of xenobiotic me-
tabolizing enzymes in primary hepatocytes after exposure to GRE
and aspalathin at nontoxic levels.






























l.CYPs, Cyp3A and 1a1/1a2, nuclear receptors, ATP-binding cassette
(ABC) transporters, and phase II transferases genes, Gst, Sult, Ugt,
and Nat were not significantly affected. In the kidneys, only six of
the 84 xenobiotic metabolism-associated genes analyzed were
significantly (p ≤ 0.05) affected by GRE (▶ Table 1). The genes en-
coding Gstm1 and Mgst1 were upregulated, whereas Abcb1,
Cyp4b1, Ggt1, and Nat1 were downregulated.
Experiments in primary hepatocytes were conducted at “non-
toxic” levels (i.e., concentrations that provided at least 80% cell
viability). These concentrations of GRE and aspalathin were below
their IC50 levels (▶ Table 2). GRE had no effect on the expression
of Comt, Hsd17β2, and Cyp2e1 (▶ Table 3). Aspalathin, however,
significantly (p ≤ 0.05) increased the expression of Comt and
downregulated the Hsd17β2 gene while marginally increased the
expression of Cyp2e1. Compared to the concentration of aspala-
thin used, its equivalent concentration in GRE was approximately
40-fold below when considering the IC50 for cytotoxicity
(0.12mg/mL) and 30-fold below the level used for the gene ex-
pression analyses (0.025mg/mL). This was based on an aspalathin
concentration of 18.4% in the GRE.GRE 0.83 (0.15) 1.18 (0.62) 1.10 (0.21)
Aspalathin + 2.05 (0.04) − 0.68 (0.05) + 1.65 (0.07)
Data normalized against the Hprt1 reference gene. Control (untreated)
group set as fold = 1. p ≤ 0.05 designated as significant and values are





Many plant constituents, and more specifically flavonoids, are
known to affect xenobiotic metabolizing enzymes by altering the
metabolic fate of drugs [6]. In this regard, specific polyphenol-
CYP450 interactions have a significant impact on the efficiency
of drug therapies [13]. Studies on rooibos herbal tea extracts indi-
cated that specific herb-drug interactions should be considered
[8,10], as rooibos extracts exhibit various beneficial health pro-
moting effects including antioxidant activity, immune responses,
anticancer, and more recently antidiabetic and anti-inflammatory
effects [4,11,14,15].
The present study represents the first investigation on the in
vivo effects of an aspalathin-enriched GRE on the expression of
genes encoding xenobiotic metabolizing enzymes in rat liver and
kidneys by qRT‑PCR array analyses. In the liver, the Gpi gene, en-
coding the enzyme catalyzing the conversion of glucose-6-phos-
phate to fructose-6-phosphate in the second step of glycolysis,
was upregulated by GRE. Malignant cells increase their expression8
of glycolytic enzymes such as Gpi and Hk2, as well as glucose up-
take resulting in production of ATP and synthesis of nucleic acids
and lipids essential for cell survival and division. Normal cells ex-
hibit metabolic flexibility and are capable of regulating their de-
pendence on glycolysis relative to mitochondrial respiration, al-
lowing the cells to adapt with the prevailing nutrient availability
or energy demands [16]. Rooibos may therefore, favor anaerobic
glycolytic metabolism, which appears to be a natural adaptation
to reduce oxygen availability [17]. The redirection of energy me-
tabolism toward glycolysis may also reduce oxidative damage and
suppresses apoptosis as reflected in cancer cells [18]. The Ald1a1Abrahams S et al. Differential Modulation of… Planta Med 2019; 85: 6–13
▶ Fig. 2 Schematic diagram of key enzymes involved in the me-
tabolism of steroid hormones modulated by GRE in the liver of rats.
↓ Indicates gene (Cyp17β2) downregulated, ↑ indicates gene
(Ctp19a1) upregulated and their involvement in the regulation of






























l.gene, responsible for the catalysis of acetaldehyde to acetate, its
less toxic form, and thus important in alcohol metabolism, was
upregulated. The concurrent ingestion of GRE and alcohol there-
fore may be beneficial in the prevention of adverse effects follow-
ing excessive alcohol consumption. This is in agreement with a
study indicating that green tea (Camellia sinensis) extract also pro-
motes alcohol metabolism [19].
GRE upregulated the Cyp19a1 (aromatase) gene in the liver,
while the expression of Hsd17β2 (hydroxysteroid dehydrogenase)
was downregulated. These enzymes play a key role in the metab-
olism of steroid hormones in the liver since Hsd17β2 encodes for
the enzyme converting estradiol, testosterone, and 5α-dihydro-
testosterone to their respective less active forms, estrone, andro-
stenedione, and 5α-androstanedione (▶ Fig. 2) [20]. Androstene-
dione, a product of cholesterol catabolism, can be reversibly con-
verted to testosterone by Hsd17β3 or to estrone by Cyp19a1. Es-
trone and testosterone can be converted to estradiol by Hsd17β1
and Cyp19a1, respectively [21]. In addition to the direct testoster-
one conversion to 5α-dihydrotestosterone by 5α-reductase, the
latter can also be derived from androstenedione via 5α-androsta-
nedione through 5α-reductase and Hsd17β3. This pathway also
seems to be effected due to the reduced expression of Hsd17β2,
responsible for the oxidation of 5α-dihydrotestosterone into 5α-
androstanedione. It would appear that GRE potentially could reg-
ulate gene expression of steroidogenic enzymes resulting in the
impairment of the breakdown of estradiol, testosterone, and 5α-
dihydrotestosterone in the liver while promoting the conversion
of androstenedione into estrone and testosterone to estradiol.
Modulation of the expression of these two enzymes may be desir-
able in normal cells, since it promotes proliferation after cell dam-
age [22], but not in cancer cells where it would promote tumor
growth. It is known that increased estrogen levels in the blood
and interaction with insulin with the subsequent increase in the
insulin growth factor are associated with endometrial cancers in
postmenopausal women [23]. The role of hydroxysteroid dehy-
drogenases in prostate cancer is also of interest as it was shown
that Hsd17β2 was down- and Hsd17β3 upregulated in the cancerAbrahams S et al. Differential Modulation of… Planta Med 2019; 85: 6–13tissue [24]. In this regard, Hsd17β2 plays an important role in the
inactivation of sex steroids in peripheral tissue, specifically testos-
terone and the reactive metabolite dihydrotestosterone that plays
a key role in prostate cancer development [20]. The subsequent
downregulation of Hsd17β2 and upregulation of Cyp19a1 by GRE
in the liver are likely to increase the blood levels of testosterone,
dihydrotestosterone, and estradiol. In this regard, the flavone
aglycone, apigenin, exhibits anti-aromatase and anti-17β-hy-
droxysteroid dehydrogenase activity [25], which could be of inter-
est as the apigenin glucosides in rooibos, vitexin and isovitexin,
could modulate the activity of these enzymes. A recent study in-
dicated that rooibos disrupts glucocorticoid metabolism in hu-
mans in vivo by increasing the level of cortisone resulting in a de-
crease in the cortisol : cortisone ratio [26]. In rats, rooibos de-
creased corticosterone and deoxycorticosterone levels as well as
the cortisone : testosterone ratio following a gavage treatment
for 10 d. In vitro studies indicated that rooibos inhibited the 11β‐
hydroxysteroid dehydrogenase type 1 (11βHSD1) resulting in an
decrease in the cortisol : cortisone ratio [26]. The disruption of
key steroid-metabolizing enzyme, 11βHSD1 related to cortisol
metabolism as well as the downregulation of Hsd17β2 expression
(current study) by rooibos provide interesting scenarios related to
the interaction of rooibos with steroidogenesis and steroid me-
tabolism which should be further explored.
Although only marginally downregulated, Alox15 and MPO
genes are of interest as they represent NF-κB target genes related
to inflammation, suggesting that rooibos is likely to exhibit anti-
inflammatory effects by inhibition of NF-κB activation. Recent
studies indicated that rooibos exhibited anti-inflammatory effects
in skin keratinocytes [15], while aspalathin and nothofagin was
found to reduce LPS-induced vascular inflammatory responses in
vivo and in endothelial cells in vitro by the suppression of TNF-α
and IL-16 production via the protection against NF-κB activation
[27].
Of the selected genes monitored in primary rat hepatocytes,
none were affected by GRE, while aspalathin significantly upregu-
lating the Comt and marginally the Cyp2e1 genes while downregu-
lating the expression of Hsd17β2, similar to GRE in the liver. This
would imply that aspalathin is likely to contribute in the downreg-
ulation of the Hsd17β2 gene by GRE. No effect was noticed for
GRE on the expression of Hsd17β2 in primary hepatocytes, which
could be related to a masking effect by other polyphenolic constit-
uents exhibiting an opposite effect, short duration of exposure or
the low dose of exposure. The aspalathin concentration associated
with GRE was 30-fold lower when compared to the concentration
of pure aspalathin used. A similar effect was noticed for the Comt
and Cyp2e1 gene expression by GRE, which could also be related
to the low equivalent dose level of aspalathin. These enzymes play
an important role in the deactivation of catechol estrogen metab-
olites, lowering their DNA damaging potential [28]. Of interest is
that, further to the effect on steroid metabolism, polyphenols also
inhibit Comt-mediated O-methylation of catechol estrogens due
to its higher affinity for the enzyme, which could further adversely
impair the activity of the enzyme [29]. The upregulation of
Cyp2e1 is of interest as the gene encodes for the enzyme involved
in quinol formation of estrogens, which also has the potential to































l.the major hepatic CYP450 enzymes in the liver responsible for
metabolizing toxins and carcinogens, such as carbon tetrachlo-
ride, N-nitrosodimethylamine, and acetaminophen [31]. It is in-
volved in the metabolism of alcohol into acetaldehyde and sug-
gested to play an important role in alcohol-induced liver damage
via oxidative DNA damage [32]. However, the upregulation of
Ald1a1 by GRE in vivo in the liver is likely to effect by the removal
of acetaldehyde which further support the view that rooibos al-
ters alcohol metabolism.
Metabolism of long chain fatty acids via ω-1 hydroxylation by
Cyp2E1, among other CYPs, results in the formation of hydroxy
metabolites, products that constrict arterioles, elevates blood
pressure, and promotes inflammation responses by modulating
cell signaling pathways related to diabetes, obesity, and carcino-
genesis [33]. The cytochrome is also involved in epoxygenase ac-
tivity of docosahexaenoic and eicosapentaenoic acids with prod-
ucts that exhibit opposite effects compared to that derived from
arachidonic acid. Overexpression of Cyp2e1 and related carcino-
gen reactions may inadvertently produce reactive oxygen species
and, when not regulated properly, could result in negative physio-
logical effects [34]. A recent in vitro study indicated that fer-
mented and unfermented rooibos extracts and aspalathin exhibit
specific herb drugs-interactions by inhibiting CYP450s involved in
the metabolism of the hypoglycemic and dyslipidemic drugs [10].
In the kidneys, GRE modulated expression of several genes–
that is, upregulation of Gstm1 and Mgst1 enzyme genes and
downregulation of the carcinogen-activating cytochrome P450,
Cyp4b1, and Nat1 genes. Gst enzymes play an important role in
the detoxification of electrophilic compounds, including carcino-
gens, therapeutic drugs, environmental toxins, and products of
oxidative stress by conjugation with glutathione in different or-
gans [35]. Therefore, GRE may play a protective role against the
development of carcinogen and/or oxidative stress-induced DNA
damage. However, the upregulation of these phase II enzymes re-
lates to the nrf2-regulated genes via antioxidant-responsive ele-
ment activation, which could imply a responsive effect to pro-ox-
idant or electrophile effects induced by GRE in the kidneys. Of in-
terest is that both the Cyp4b1 and Nat1 genes are associated with
the development of bladder cancer, with the former involved in
the activation of 2-aminofluorene [36] and the latter in the activa-
tion of arylamine metabolites through O-acetylation and N,O-ace-
tylation [37]. In this regard, GRE seems to play a protective role in
counteracting the generation of these reactive metabolites in the
kidneys. The downregulation of the glutathione-depletion en-
zyme gene, Ggt1, further suggest that GRE could protect against
carcinogens when utilizing the glutathione conjugation deactiva-
tion pathway. Glutathione degradation occurs in the proximal
tubule at both the luminal [38] and basolateral membrane [39],
a process that is modulated by GRE, presumably due to changes
in GSH metabolism.
GRE downregulated the Abcb1 gene in the kidneys. The ABC
transporters form part of the phase III drug transporters and con-
stitute a ubiquitous superfamily of integral membrane proteins
responsible for the translocation of many substances across mem-
branes. Although this may be advantageous in the treatment of
cancer during chemotherapy, the protection of normal cells
against toxic compounds may be impaired. Cancer cells are10known to increase the expression of ATP-dependent efflux pumps,
the ABC transporters including P-glycoprotein (Abcb1), which are
associated with drug resistance [40]. Therefore, ABC transporters
are one of the most critical targets in the treatment of cancer, es-
pecially those exhibiting drug resistance. It would appear that GRE
could selectively alter these pathways and may therefore be used
to sensitize the susceptibility of cancer cells to anticancer drugs in
the kidneys. However, GRE may also prevent the transport of its
polyphenols from the kidneys. Of interest is that the expression
of the phase II enzymes is predominantly affected in the kidneys
compared to the liver, which is regarded as the major organ for
drug metabolism. However, the kidneys play a major role in the
metabolism of drugs, hormones, and xenobiotics, and in some
cases, such as the enzymes involved in the processing of gluta-
thione conjugates to their mercapturic acids, biotransformations
occur at a faster rate in the kidneys [41].
When extrapolating the average dietary TP intake of 76mg
GAE/kg BW/d to a HED [42], it amounts to 12.3mg GAE/kg BW/
d. The aspalathin intake of 36mg/kg BW/d by the rats equals a
HED of approximately 6mg/kg BW/d. Based on 1.2mg aspala-
thin/200mL of a fermented rooibos infusion equaling 1 cup [43],
humans (70 kg BW) consuming 6 cups of rooibos per day, as sug-
gested by Marnewick et al. [44], have a daily intake of 0.1mg as-
palathin/kg. When consuming 6 cups of green rooibos infusion at
31mg aspalathin/200mL [5], the daily intake of aspalathin will
equal 2.7mg/kg BW. This is approximately 13-fold lower when
compared to the current exposure in rats and two-fold lower
when considering the HED. However, specific safe levels of expo-
sure should be considered as the current study indicated that the
expression of drug metabolic enzymes is altered and that a longer
duration of exposure also alters the expression of oxidative stress
and antioxidant-related defense genes in the liver, as well as re-
ducing iron absorption [12]. In this regard, specific tolerable up-
take levels of exposure to plant bioactive nutrients to address
health benefits and safety/toxicity have been suggested in order
to define thresholds of exposure, thereby minimizing adverse
chronic effects [45].
In conclusion, the genes involved in alcohol, energy, and phase
I enzymes related to steroid metabolism in the liver were altered.
Differences as well as similarities were observed between the in
vivo study in rats and in primary hepatocytes with respect to the
expression of genes related to estrogen and alcohol metabolism.
This could be due to variations in the dose level and duration of
exposure to GRE and aspalathin. In the kidneys, however, mostly
phase II genes, transporters and only certain phase I genes were
altered. As the kidney is the main organ for excretion of drugs,
hormones, and xenobiotics, modulation of these enzymes could
have important functional implications following chronic expo-
sure to polyphenol-enriched pharmaceutical products. Detailed
investigations assessing changes in the expression profiles of the
genes at a protein level would provide more information about
the validity of these alterations at a cellular level.
HPLC‑DAD chromatogram of ARC2 at 288 nm (1, Z-2-(β-D-glu-
copyranosyloxy)-3-phenylpropenoic acid, 0.49%; 2, isoorientin,
2.05%; 3, orientin, 1.05%; 4, aspalathin, 18.44%; 5, quercetin-3-
O-robinobioside, 1.05%; 6, vitexin, 0.27%; 7, hyperoside, 0.27%;
8, rutin, 0.54%; 9, isovitexin, 0.39%; 10, isoquercitrin, 0.38%; 11,Abrahams S et al. Differential Modulation of… Planta Med 2019; 85: 6–13
nothofagin, 1.29%) is available as Supporting Information. Insert
shows chromatogram of sample at 288 nm with y-axis adjusted
































dihydrochalcone) was purified from unfermented rooibos at the
Institute of Biomedical and Microbial Biotechnology, Bellville,
South Africa, to a purity of > 95%. WE, HBSS, HEPES, rat tail colla-
gen type 1, collagenase type 4, insulin, sodium-pyruvic acid, L-
glutamine, L-proline, ethylene glycol tetraacetic acid, DMSO,
Eagleʼs minimal essential medium, and molecular biology grade
β-mercaptoethanol (β-ME) were purchased from Sigma-Aldrich.
FBS was obtained from Invitrogen. Penicillin, streptomycin, fungi-
zone (amphotericin B), trypan blue, and MEM nonessential amino
acid solution were obtained from Lonza. Analytical grade metha-
nol, ethanol, and hydrochloric acid were purchased from Merck
Chemicals.
GRE
The aspalathin-enriched GRE (GRC2) was prepared according to a
patented process and supplied by Raps Foundation [46]. In short,
the plant material was extracted with 80% ethanol-water mixture
and dried under vacuum-drying. The chlorophyll of the dried ex-
tract extracted was removed with ethyl acetate and the residue
vacuum-dried and stored at − 20°C until used. The aspalathin-en-
riched GRE contained 18.4% aspalathin, 1.3% nothofagin, 3.8%
flavones (orientin, isoorientin, vitexin, and isovitexin), and 2.2%
flavonols (quercetin glycosides) as detailed by HPLC‑DAD analysis
[11]. A detailed HPLC chromatogram is provided as a supplemen-
tary file. The TP in the extract, according to the Folin-Ciocalteu
method, was 39.2 g GAE/100 g extract [12].
Animal study design
Details of the animal study have been described in detail else-
where [12] and was approved by the Ethics Committee for Re-
search on Animals of the South African Medical Research Council
(Ref No. 05/07; April 17, 2007). Seven- to eight-week-old male
Fischer (F344) rats (n = 10), weighing between 150 and 200 g
were divided into two groups: the control group receiving a nor-
mal diet (Epol Ltd.) and a treatment group receiving the same diet
supplemented with GRE (0.2%) for 28 d. This GRE dose was se-
lected based on HED consuming six cups of green rooibos per
day (details in the Discussion section). All the rats had free access
to the feed and water. Upon termination, rats were fasted over-
night, sacrificed by cervical dislocation, and tissue sections of the
liver and kidneys harvested and (200–400mg) immediately snap
frozen in liquid nitrogen and stored at − 80 °C until gene expres-
sion analyses of the xenobiotic metabolizing enzymes. Five liver
and kidney samples were randomly selected of the rats from each
treatment and control groups.Abrahams S et al. Differential Modulation of… Planta Med 2019; 85: 6–13qRT‑PCR
Total RNA was isolated from the liver and kidney tissue (20–
25mg) of three rats in each treatment and control group using
the RNeasy mini kit according to the manufacturerʼs instructions
(Qiagen). Tissue samples were homogenized in a Tissuelyser II
(Qiagen) for 40 s and the RNA eluted with RNase-free water
(50 µL). Genomic DNA contamination was removed using the
Ambion Turbo DNA-free kit (Applied Biosystems) according to
the manufacturerʼs recommendations. RNA was quantified using
a Nanodrop 1000 spectrophotometer (Thermo Scientific) and the
RNA integrity confirmed by determining the RNA 28S:18S ratio
using a Bioanalyzer 2100 (Agilent Technologies). The isolated
RNA samples were stored at − 80 °C. First strand complimentary
deoxyribonucleic acid (cDNA) synthesis was carried out using the
RT2 First Strand Kit (Qiagen) according to the manufacturerʼs pro-
tocol and samples stored at − 20°C until further use.
qRT‑PCR array analyses of the samples were done in triplicate.
The cDNA (20 µL) was further diluted in nuclease-free water to a
final volume of 111 µL. An aliquot (102 µL) was mixed with a twice
concentrated RT2 qPCR SYBR green I master mix (550 µL)
(Qiagen), containing HotStart DNA polymerase and nuclease-free
water (448 µL) to a final volume of 1100 µL. The cDNA mixture
(10 µL) was transferred to a PCR profiler array (Qiagen) containing
84 genes, coded for xenobiotic metabolizing enzymes and trans-
porters, five reference genes, and quality control parameters
(http://www.sabiosciences.com/PCRArrayPlate.PhP). Data were
generated using an ABI 7900HT RT‑PCR apparatus (Applied Bio-
systems) with a two-step cycling program (1 cycle at 95 °C for
10min; 40 cycles at 95 °C for 15 sec and then at 60 °C for 1min).
The data were analyzed using the Microsoft Excel-based PCR array
data analysis template from Qiagen (http://www.superarray.com/
pcrarraydata analysis.php). All samples were analyzed in triplicate.
The mean Ct value for the genomic DNA control (GDC) parameter
of each sample was determined and a gene-by-gene analysis for
each gene of interest (GOI) was done using the equation ΔCt(GOI)
= Ct (GDC) – Ct (GOI). Five reference genes (Rplp1, Hprt1, Rpl13a,
Ldha, and Actb) were used for normalization. The relative number
of transcripts in the treated and control was calculated according
to the comparative Ct (ΔΔCt) method. The fold-change for each
treated sample relative to the control sample was calculated using
the formula of 2-ΔΔCt. Statistical calculations were conducted,
based on the ΔCt values, using a two-tailed t-test and p ≤ 0.05
was designated as significant.
In vitro studies utilizing primary rat hepatocyte
cultures
Primary hepatocytes were isolated frommale Fischer 344 rats (ca.
200 g/rat) according to the collagenase perfusion technique [47].
Cell viability was determined using trypan blue exclusion stain and
hepatocyte cultures yielding a viability of greater than 80% were
used. Cells were plated in WE containing 10% FBS, insulin (20 U/L),
L-glutamine (2mM), HEPES (10mM), penicillin (100 U/ml), and
streptomycin (100 µg/mL) for 3 h at 37 °C. Cells were washed twice
with HBSS and supplemented with modified WE (200 µL in 96-well
plates or 2mL in 60mm plates) containing 0.5% FBS, L-proline
(2mM), and sodium pyruvate (10mM), in addition to the other
components described above, and incubated for 24 h at 37 °C in11
▶ Table 4 Primer sequences of selected genes for qPCR analyses in primary hepatocytes.
Gene Genebank Sense Antisense
5′→3′ 5′→3′
Comt NM_012531 CCATGGAGATGAACCCTGACTAC TAGGCCTGCAAAGT TCAGCAT T
Cyp2e1 NM_031543 T TGGCCGACCTGT TCT T TG T T TCTGGGTAT T TCATGAGGATCA
Hsd17β2 NM_024391 CGCAGAGAAGATACAAGACAAAGG AAAGTGCAAGACCCCAGCAT































l.air/carbon dioxide (95 :5). Different concentrations of GRE or aspa-
lathin (100 µL) were added to the respective wells of a 96-well
opaque-walled microtiter plate and the plate incubated for 24 h at
37 °C in air/carbon dioxide (95 :5).
Cell viability assay
Cells were plated at a density of 2 × 104 viable cells in collagen-
coated 96-well opaque-walled plates for the cell viability assay.
GRE dilutions (0.2, 0.1, 0.05, 0.025mg/mL) and aspalathin (2.0,
1.25, 0.63, 0.31, 0.16mM) were prepared in modified WE culture
medium to a final DMSO concentration of 1%. A 1% DMSO culture
medium solution was used as control. Cell viability was deter-
mined based on the assessment of ATP production as a measure
of metabolically active cells, using the CellTitre-Glo assay
(Promega) according to the manufacturerʼs protocol. The lumi-
nescence signal was recorded using a Veritas Microplate Lumin-
ometer (Turner Biosystems). The percentage ATP inhibition was
determined and the respective IC50 values (concentration of GRE
and aspalathin required to inhibit 50% ATP production in the cell)
calculated using GraphPad Prism 5 software. The assay was re-
peated five times to obtain average IC50 values for GRE and aspa-
lathin.
Gene expression analyses in primary hepatocytes
Hepatocytes (≥ 80% viability) were plated at a density of 3 × 106
viable cells in collagen-coated culture dishes (60mm) for RNA ex-
tractions. The cells were exposed to nontoxic levels below the IC50
values of GRE (0.025mg/mL) and aspalathin (0.31mM) (▶ Table
2) for 24 h at 37 °C as describe above. Each treatment and control
were repeated four times in a total volume of 2mL per tissue cul-
ture dish. The hepatocyte cultures were washed with ice-cold
phosphate buffered saline (pH7.4) and collected in RLT buffer
(350 µL/dish) (Qiagen), containing guanidine isothiocyanate and
β-mercaptoethanol. The cells in four tissue culture dishes were
combined into clean nuclease-free tubes and lysed in liquid nitro-
gen. Total RNA was isolated, and cDNA synthesized as described
above. The gene expression of three xenobiotic metabolizing
genes (Comt, Cyp2e1, Hsd17β2) were analyzed by qRT‑PCR with
the hypoxanthine guanine phosphoribosyltransferase 1 (Hprt1)
gene as an endogenous control. Gene-specific qPCR primers
(▶ Table 4) were designed using the Primer Express software
v2.5 (Applied Biosystems) and synthesized by Integrated DNA
Technologies Inc. (IDT). The qRT‑PCR array and statistical analyses
were conducted as described above.12Supporting Information
HPLC‑DAD chromatogram of ARC2 at 288 nm (1, Z-2-(β-D-gluco-
pyranosyloxy)-3-phenylpropenoic acid, 0.49%; 2, isoorientin,
2.05%; 3, orientin, 1.05%; 4, aspalathin, 18.44%; 5, quercetin-3-
O-robinobioside, 1.05%; 6, vitexin, 0.27%; 7, hyperoside, 0.27%;
8, rutin, 0.54%; 9, isovitexin, 0.39%; 10, isoquercitrin, 0.38%; 11,
nothofagin, 1.29%). Insert shows chromatogram of sample at
288 nm with y-axis adjusted to show full aspalathin peak height.
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